Management of Stage IIIA (N2) Non-Small Cell Lung Cancer

被引：22

作者：

Gillaspie, Erin A. ^{[1
]}

Wigle, Dennis A. ^{[1
]}

机构：

[1] Mayo Clin, Div Thorac Surg, 200 First St, Rochester, MN 55905 USA

来源：

THORACIC SURGERY CLINICS | 2016年 / 26卷 / 03期

关键词：

Stage IIIA; Non-small cell lung cancer; PORT; Adjuvant; Neoadjuvant; Surgery; N2; TRIALIST ASSOCIATION ANITA; POSTOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; RANDOMIZED-TRIAL; NEOADJUVANT THERAPY; SURGICAL RESECTION; DOSE RADIATION;

D O I：

10.1016/j.thorsurg.2016.04.001

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

There is no consensus as to the optimal management of IIIA (N2) non-small cell lung cancer, nor for the role of surgery in treating this disease stage. Clinical trial evidence struggles to keep up with technology advancement and the evolution of expert opinion. Despite advances in chemotherapeutic regimens, methods of delivery for radiation, and less invasive surgical techniques, survival for patients with stage IIIA-N2 malignancies remains poor. Further developments in both will stimulate and maintain controversy in the field for years to come.

引用

页码：271 / +

页数：17

共 63 条

[61] Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer [J].

Weder, Walter ;

Collaud, Stephane ;

Eberhardt, Wilfried E. E. ;

Hillinger, Sven ;

Welter, Stefan ;

Stahel, Rolf ;

Stamatis, Georgios .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (06) :1424-1430

[62] The beginning of the end of mediastinoscopy? [J].

Wigle, Dennis A. .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) :561-562

[63]

Yasafuku K, 2011, 91 ANN M AM ASS THOR

← 1 2 3 4 5 6 7 →